Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-)

NCT02418481 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: DC-CIK
BIOLOGICAL: γδ T Cell
BIOLOGICAL: Combination

Sponsor

Fuda Cancer Hospital, Guangzhou

Collaborators

[object Object]